BioinformaticsbioRxivPreprint
In Silico identification and modelling of FDA-approved drugs targeting T-type calcium channels
Pedro Fong, Susana Román García, Melanie I. Stefan, David C. Sterratt
This paper identifies montelukast, an FDA-approved asthma drug, as a potential inhibitor of the Cav3.1 T-type calcium channel through computational simulations and suggests it may have therapeutic potential for neurological diseases.
DOI 10.1101/2024.09.27.615366